CYT997 Terminated Phase 2 Trials for Relapsed and Refractory Multiple Myeloma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00664378Efficacy Study of CYT997 in Multiple Myeloma